Dear Editor, We read with interest the paper by Franasiak et al. entitled BDehydroepiandrosterone (DHEA) supplementation results in supraphysiologic DHEA-S serum concentrations and progesterone assay interference that may impact clinical management in IVF^ [1] . This paper provided evidence that DHEA supplementation could lead to increased circulating DHEA-S concentrations and clinically significant false elevations in progesterone results. This interference is particularly relevant at the progesterone concentration where the embryo transplant is decided [2] . However, we have concerns regarding discrepancies on the DHEA-S concentrations reported by these authors through the manuscript.
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The units reported in Fig. 2 of the authors' article is μg/dL while the remainder of the text and figure/table legends use μg/mL [1] . The authors also claim in their conference abstract [3] that the concentration of the Siemens ADVIA Centaur DHEA-S controls range from 0 to >1500 μg/mL. However, the package insert indicates that these materials have concentrations of 0 to 1500 μg/dL (0-15.0 μg/mL). In addition, a review of commercially available DHEA-S assays reveals that the analytical and reportable range for DHEA-S is 0-1500 μg/ dL (0-15 μg/mL) ( Table 1) . We also replicated part of the experiment performed by the authors [1] using our Siemens ADVIA Centaur assay. We measured an aliquot of our high and low DHEA-S calibrator on the progesterone assay to determine degree of cross reactivity. Our 0 μg/dL DHEA-S calibrator yielded a progesterone of 0.4 ng/mL while our highest DHEA-S calibrator (1500 μg/dL or 15.0 μg/mL) yielded a progesterone of 1.0 ng/mL. These inconsistencies between the results of our investigations and those of Franasiak et al. can be explained by the use of incorrect units in the authors' publication and conference abstract.
There are also physiological arguments against the very high DHEA-S concentrations referenced by Franasiak et al. Our harmonized reference interval for DHEA-S in Northern Alberta, Canada, is <405 μg/dL (<4.1 μg/mL) for females aged 11-50 years. Serum DHEA-S concentration in females without oral DHEA supplementation were reported in the range of 13,100-14,200 μg/dL (131-142 μg/mL), which is 33 × higher than our reference interval. They further reported that patients with oral DHEA-S supplementation showed a doubling of serum DHEA-S concentration in the range of 2 8 , 4 0 0 -2 9 , 3 0 0 μ g / d L ( 2 8 4 -2 9 3 μ g / m L ) . T h i s supraphysiological DHEA-S concentration is difficult to achieve unless mega-doses of DHEA oral supplements are consumed in concert with impaired metabolism and excretion.
In conclusion, we believe that the DHEA-S concentrations reported by Franasiak et al. [1] should be in μg/dL instead of μg/mL. When the corrected units are used, serum DHEA-S concentrations in IVF patients not on DHEA supplements will be 131-142 μg/dL (1.3-1.4 μg/mL), while those receiving DHEA will be 284-392 μg/dL (2.8-3.9 μg/mL). These results are consistent with our current reference intervals as well as the physiological circulating DHEAS concentrations reported in the literature [4] [5] [6] . Fortunately, many manufacturers have verified that their progesterone assays are not significantly affected by DHEA-S at these physiological concentrations, with the exception that Siemens assays reported up to a 370% increase in progesterone when DHEA-S was 500 μg/ dL (5.0 μg/mL). Nevertheless, Franasiak et al. should be commended for their idea of studying the effects of DHEA supplementation on progesterone concentrations in patients undergoing IVF. Although DHEA-S remains within the reference interval for patients treated with DHEA and the interference on progesterone assays occur at a much lower concentration than initially reported [7] , this interference is particularly relevant at the progesterone concentration where the transplant of the embryo is decided.
